USNA
USANA Health Sciences Inc.
$18.74
+$0.18(+0.97%)
46
Overall
70
Value
36
Tech
34
Quality
Market Cap
$363.42M
Volume
93.29K
52W Range
$16.60 - $38.32
Target Price
$39.00
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $1.0B | $1.0B | $1.2B | $1.1B | $1.1B | $1.2B | $998.6M | $921.0M | $854.5M | $925.3M | ||
| Total Revenue | $1.0B | $1.0B | $1.2B | $1.1B | $1.1B | $1.2B | $998.6M | $921.0M | $854.5M | $925.3M | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $-180.2M | $-179.4M | $200.7M | $187.5M | $209.1M | $217.9M | $193.9M | $176.7M | $161.2M | $200.9M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $825.9M | $867.9M | $988.5M | $873.4M | $925.5M | $968.6M | $804.7M | $744.3M | $693.3M | $724.4M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-687.3M | $-735.4M | $800.2M | $727.2M | $749.0M | $798.4M | $697.1M | $651.2M | $627.0M | $687.0M | ||
| Research & Development | $-8.8M | $-9.0M | $-10.2M | $10.3M | $10.6M | $11.1M | $11.6M | $11.4M | $11.6M | -- | ||
| Research Expense | -- | -- | -- | $10.3M | $10.6M | $11.1M | -- | -- | -- | -- | ||
| Selling, General & Administrative | $234.2M | $265.1M | $275.1M | $267.7M | $261.2M | $279.1M | $262.3M | $257.0M | $263.3M | $337.4M | ||
| Selling & Marketing Expenses | $234.2M | $265.1M | $275.1M | $11.6M | $9.9M | $12.4M | $5.1M | $4.8M | $5.0M | -- | ||
| General & Administrative Expenses | $-10.2M | $-10.9M | $-11.2M | $267.7M | $261.2M | $279.1M | $262.3M | $257.0M | $263.3M | $337.4M | ||
| Promotion & Advertising | $-12.3M | $-11.5M | $-10.3M | $11.6M | $9.9M | $12.4M | -- | -- | -- | -- | ||
| Salaries & Wages | $-16.5M | $-15.5M | $-15.0M | $-2.7M | $-2.5M | $-2.8M | -- | -- | -- | -- | ||
| Depreciation & Amortization | $-11.9M | $-14.5M | $-15.2M | $13.1M | $12.2M | $11.7M | $11.4M | $12.7M | $14.5M | -- | ||
| Depreciation & Amortization | $-11.9M | $-14.5M | $-15.2M | $13.1M | $12.2M | $11.7M | -- | -- | -- | -- | ||
| Amortization | $-1.5M | $-1.5M | $-1.5M | $29.8M | $30.8M | $30.4M | $32.4M | $29.9M | $151.8M | -- | ||
| Other Operating Expenses | $453.1M | $470.3M | $525.1M | $-459.5M | $-487.9M | $-519.3M | -- | -- | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $138.6M | $132.5M | $188.4M | $146.2M | $176.5M | $170.2M | $107.6M | $93.1M | $66.3M | $37.4M | ||
| EBITDA | $152.5M | $150.8M | $208.4M | $173.6M | $201.0M | $192.9M | $130.2M | $123.1M | $98.9M | $82.1M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $444.0K | $46.0K | $36.0K | $66.0K | $507.0K | $57.0K | $192.0K | $262.0K | $281.0K | $842.0K | ||
| Intinc | $1.5M | $2.2M | $4.4M | $4.7M | $2.5M | $2.5M | $3.8M | $9.6M | $11.3M | $2.4M | ||
| Net Non-Operating Interest Income/Expense | $1.0M | $2.1M | $4.4M | $4.6M | $2.0M | $2.5M | $3.6M | $9.4M | $11.0M | $1.6M | ||
| Gain on Sale of Securities | -- | -- | -- | $276.0K | -- | -- | -- | -- | -- | -- | ||
| Other Income/Expense | $1.1M | $3.0K | $1.2M | $335.0K | $571.0K | $2.0M | $-2.6M | $-7.0K | $1.0M | $-2.5M | ||
| Other Special Charges | $-1.1M | $-3.0K | $-1.2M | $-335.0K | $-571.0K | $-2.0M | $-2.6M | $7.0K | $-1.0M | $2.5M | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $6.5M | ||
| Special Income Charges | -- | $2.7M | -- | -- | -- | -- | -- | -- | -- | $-13.4M | ||
| Impairment of Capital Assets | -- | $-2.7M | -- | -- | -- | -- | -- | -- | -- | $7.0M | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $139.0M | $134.7M | $191.5M | $150.6M | $178.5M | $170.7M | $108.8M | $102.7M | $76.6M | $42.4M | ||
| Pre-Tax Income | $138.6M | $134.6M | $191.5M | $150.5M | $177.9M | $170.6M | $108.6M | $102.5M | $76.4M | $41.5M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $38.5M | $72.1M | $65.3M | $50.0M | $53.3M | $54.1M | $39.3M | $38.7M | $34.3M | $30.1M | ||
| NET INCOME | ||||||||||||
| Net Income | $100.0M | $62.5M | $126.2M | $100.5M | $124.7M | $116.5M | $69.3M | $63.8M | $42.0M | $10.8M | ||
| Net Income (Continuing Operations) | $100.0M | $62.5M | $126.2M | $100.5M | $124.7M | $116.5M | $69.3M | $63.8M | $42.1M | $11.5M | ||
| Net Income (Discontinued Operations) | $100.0M | $62.5M | $126.2M | $100.5M | $124.7M | $116.5M | $69.3M | $63.8M | $42.0M | $10.8M | ||
| Net Income (Common Stockholders) | $100.0M | $62.5M | $126.2M | $1.0B | $124.7M | $116.5M | $69.3M | $63.8M | $42.0M | $10.8M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $54.5M | ||
| TOTALS | ||||||||||||
| Total Expenses | $-867.5M | $-914.8M | $1.0B | $914.7M | $958.2M | $1.0B | $891.0M | $827.9M | $788.2M | $887.8M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $24.2M | $24.3M | $24.1M | $22.6M | $21.2M | $20.1M | $19.3M | $19.3M | $19.1M | $18.5M | ||
| Average Shares Outstanding (Diluted) | $25.0M | $24.7M | $24.6M | $22.8M | $21.3M | $20.3M | $19.3M | $19.3M | $19.2M | $18.6M | ||
| Shares Outstanding | $24.5M | $24.0M | $23.3M | $21.5M | $20.9M | $19.3M | $19.3M | $19.2M | $18.9M | $18.5M | ||
| Basic EPS | $4.14 | $2.57 | $5.24 | $4.44 | $5.89 | $5.78 | $3.6 | $3.31 | $2.2 | $0.58 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | $4.44 | $5.89 | $5.78 | $3.6 | $3.31 | $2.2 | $0.58 | ||
| Diluted EPS | $3.99 | $2.53 | $5.12 | $4.41 | $5.86 | $5.73 | $3.59 | $3.3 | $2.19 | $0.58 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | $4.41 | $5.86 | $5.73 | $3.59 | $3.3 | $2.19 | $0.58 | ||
| OTHER METRICS | ||||||||||||
| Minority Interests | -- | -- | -- | -- | -- | -- | -- | -- | $-30.0K | $-717.0K | ||
| Other Gand A | $-10.2M | $-10.9M | $-11.2M | $267.7M | $261.2M | $279.1M | $262.3M | $257.0M | $263.3M | $337.4M | ||
| Rent And Landing Fees | $-10.2M | $-10.9M | $-11.2M | -- | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $234.2M | $265.1M | $275.1M | -- | -- | -- | -- | -- | -- | -- | ||
| Restruct | -- | -- | -- | -- | -- | -- | -- | -- | -- | $6.5M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | USNA | $18.74 | +1.0% | 93.29K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get USANA Health Sciences Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW